Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Free Radic Biol Med. 2010 Apr 11;49(3):307–316. doi: 10.1016/j.freeradbiomed.2010.04.004

Figure 3. Location of NOS in liver, liver cells and subcellular compartments.

Figure 3

NOS1, NOS2 and NOS3 are present in liver. NOS1 has been shown in rat hepatocytes ([140] and Villanueva et al., 2010, submitted manuscript). NOS2 and NOS3 have been demonstrated in normal human hepatocytes [26]. NOS2 is present in Kupffer cells, whereas NO3 is present at the endothelial cells of the hepatic sinusoids [26, 141]. Within the cells, the NOS isoforms are located in different subcellular compartments such as the Golgi apparatus, caveolae or mitochondria [94]. NOS1 and NOS2 can be translocated from cytoplasm to nuclei in pathological conditions such as diabetes (see Figure 4) and cirrhosis [26], respectively. Within the cell, nitric oxide produced by NOS can interact with various specific targets (soluble guanylate cyclase, cytochrome c oxidase) and other biomolecules such as lipids, proteins and carbohydrates.

HHS Vulnerability Disclosure